Home
Who we are
Who we are
Overview
Fact Sheet
Chairman's Profile
Board of Directors
Team Wockhardt
Faclities
Manufacturing
Contract Manufacturing
Virtual Tour
Global Presence
Our Footprints
Other websites
Community Care
Wockhardt Foundation
Wockhardt HIV/AIDS Care
We touch lives
R & D
Overview
Generics
New Drug Discovery
Biotechnology
Overview
Biopharmaceuticals
Biotechnology Park
Gallery
Corporate Regulatory
Marketing & Regulatory Infrastructure
Products
Search Products
Partnerships
Collaborations / Partnerships
People
Life at Wockhardt
Frequently Asked Questions
Focus on Development
Meet our People
Career Openings
Investors
Financials at a glance
Annual Reports
Quarterly Reports
Shareholding Pattern
Chairman's letter to Shareowners
Chairman's AGM Speeches
Code of Conduct
Financial Press Releases
Stock Quotes
Investor Communication
Investor Contact
Investor Meet
Media
Press Releases
Media Kit
Videos
Media Contact
Get in touch
Corporate Office
International Offices
Research Centres
Manufacturing Plants
Home
>
Media
>
Press Releases
>
Wockhardt launches generic version of anti depressant drug Wellbutrin® SR
Press Releases
< back
Wockhardt launches generic version of anti-depressant drug Wellbutrin® SR
Daryl - 03 September, 2012
Wockhardt launches generic version of anti--depressant drug Wellbutrin SR